NordicCan A/S: Financial statements 2017
CVR: 37633925
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
NordicCan A/S (CVR 37633925) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -6,000 and a net result of DKK -7,000. Equity in the 2017 report amounted to DKK 481,000. The solvency ratio was 96.8%.
- Gross Profit
- DKK -6,000
- Profit/Loss
- DKK -7,000
- Equity
- DKK 481,000
- Total Assets
- DKK 497,000
Official annual report
Keep an eye on NordicCan A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
NordicCan A/S has published its interim report for the period April 18, 2016 to December 31, 2016.
As of January 16, 2017, Erik Gregers Hansen has joined the board of directors of NordicCan A/S.
As of January 16, 2017, Søren Birn has left the board of directors of NordicCan A/S.
As of January 16, 2017, Morten la Cour Pedersen is registered as adm. dir. of NordicCan A/S.
As of January 16, 2017, Søren Birn has stepped down as adm. dir. of NordicCan A/S.
About NordicCan A/S
NordicCan A/S was a Danish company of the type Aktieselskab based in Vejle, founded in 2016. The company has been dissolved on 24 March 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MedCan Pharma A/S. The company has 22 employees (2018). In 2021, the company reported a net result of DKK -4,058,000 compared with DKK -1,987,000 the year before. Equity in the 2021 report amounted to DKK 5,767,000.